Gabelli Enterprise Value Over E B I T D A from 2010 to 2024

GRX Stock  USD 10.24  0.02  0.19%   
Gabelli Healthcare Enterprise Value Over EBITDA yearly trend continues to be fairly stable with very little volatility. Enterprise Value Over EBITDA is likely to outpace its year average in 2024. During the period from 2010 to 2024, Gabelli Healthcare Enterprise Value Over EBITDA regression line of annual values had r-squared of  0.11 and arithmetic mean of  7.60. View All Fundamentals
 
Enterprise Value Over EBITDA  
First Reported
2010-12-31
Previous Quarter
63.10097173
Current Value
66.26
Quarterly Volatility
31.26729023
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Gabelli Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Gabelli Healthcare's main balance sheet or income statement drivers, such as Interest Expense of 2.9 M, Selling General Administrative of 734 K or Total Revenue of 1.2 M, as well as many indicators such as Price To Sales Ratio of 126, Dividend Yield of 0.0562 or PTB Ratio of 0.61. Gabelli financial statements analysis is a perfect complement when working with Gabelli Healthcare Valuation or Volatility modules.
  
Check out the analysis of Gabelli Healthcare Correlation against competitors.

Latest Gabelli Healthcare's Enterprise Value Over E B I T D A Growth Pattern

Below is the plot of the Enterprise Value Over E B I T D A of Gabelli Healthcare WellnessRx over the last few years. It is Gabelli Healthcare's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Gabelli Healthcare's overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Over E B I T D A10 Years Trend
Slightly volatile
   Enterprise Value Over E B I T D A   
       Timeline  

Gabelli Enterprise Value Over E B I T D A Regression Statistics

Arithmetic Mean7.60
Geometric Mean9.38
Coefficient Of Variation411.18
Mean Deviation15.58
Median5.70
Standard Deviation31.27
Sample Variance977.64
Range142
R-Value0.33
Mean Square Error939.06
R-Squared0.11
Significance0.23
Slope2.30
Total Sum of Squares13,687

Gabelli Enterprise Value Over E B I T D A History

2024 66.26
2023 63.1
2022 -4.86
2021 5.47
2020 10.32
2019 3.98
2018 -75.81

About Gabelli Healthcare Financial Statements

Gabelli Healthcare investors use historical fundamental indicators, such as Gabelli Healthcare's Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Gabelli Healthcare. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Enterprise Value Over EBITDA 63.10  66.26 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Gabelli Stock Analysis

When running Gabelli Healthcare's price analysis, check to measure Gabelli Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gabelli Healthcare is operating at the current time. Most of Gabelli Healthcare's value examination focuses on studying past and present price action to predict the probability of Gabelli Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gabelli Healthcare's price. Additionally, you may evaluate how the addition of Gabelli Healthcare to your portfolios can decrease your overall portfolio volatility.